Unlock the full potential of antibody-drug conjugates (ADCs) with Pharmaron’s specialized ADC bioconjugation services. Our integrated platform provides seamless support for ADC development, from small molecule synthesis and antibody generation to bioconjugation, characterization, and in vivo evaluation.

Key highlights from this service overview include:

• Comprehensive Bioconjugation Expertise: Efficient synthesis of highly potent payloads, linkers, and purified antibodies with 95% purity.
• Advanced Analytical Capabilities: In-depth characterization of conjugates, including Drug-to-Antibody Ratio (DAR), free drug residue, charge variants, and glycosylation site analysis.
• End-to-End Bioassays: In vitro potency screening with 1,900+ cell lines, and in vivo efficacy, biodistribution, and GLP toxicology studies across various animal models.

Pharmaron delivers ADC solutions tailored to your drug development needs with industry-leading chromatography, mass spectrometry, and bioanalytical technologies.